Endometrial stromal sarcoma: An aggressive uterine malignancy.

OA: closed
AI-generated summary by qwen3.7-flash, 2026-09-04

This case report describes a large endometrial stromal sarcoma presenting with acute urinary retention and irregular bleeding, highlighting characteristic MRI findings to aid in distinguishing this aggressive uterine malignancy from benign conditions.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by qwen3.7-flash, 2026-08-23 · read from full text

This case report describes a 42-year-old nulliparous woman with endometrial stromal sarcoma who presented with acute urinary retention and irregular vaginal bleeding. Imaging via ultrasound, Doppler, and magnetic resonance imaging revealed a large, heterogeneous, vascular mass extending into the vagina, with characteristic linear hypointense bands on T2-weighted images aiding in diagnosis. The authors emphasize that MRI is critical for characterizing these lesions and staging the disease to distinguish them from benign or other malignant uterine conditions. This paper is centrally about endometrial stromal sarcoma, a rare uterine malignancy distinct from endometriosis and adenomyosis; relevance to endometriosis: listed as a differential diagnosis for abnormal uterine bleeding and pelvic masses, though the paper's main focus is the radiological characterization of this specific cancer.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Endometrial stromal sarcoma (ESS) is an aggressive uterine sarcoma. We report a case of a large endometrial stromal sarcoma in a 42 year nulliparous woman with chronic kidney disease presenting with acute urinary retention and irregular per vaginal bleeding. Ultrasound and Doppler imaging revealed a heterogeneous mass in the endometrial cavity with internal vascularity. Magnetic resonance imaging (MRI) revealed a large lobulated mass in the endometrial cavity extending into the vagina, causing local mass effect. Multiple linear hypointense bands on magnetic resonance T2 weighted (T2wt) images were characteristic of ESS. MRI is a very useful imaging modality in characterizing the lesion and also for the staging. It is necessary to distinguish these tumors from benign as well as other uterine malignancies for better management. We also review relevant literature discussing imaging findings of ESS.
Full text 1,978 characters · extracted from oa-doi-fallback · click to expand
Endometrial stromal sarcoma: An aggressive uterine malignancy DOI: https://doi.org/10.3941/jrcr.v10i9.2770Keywords: MRI, Uterus, Endometrial stromal sarcomas, undifferentiated endometrial sarcomas, high grade sarcomas, uterine mesenchymal neoplasms, myometrial bandsAbstract Endometrial stromal sarcoma (ESS) is an aggressive uterine sarcoma. We report a case of a large endometrial stromal sarcoma in a 42 year nulliparous woman with chronic kidney disease presenting with acute urinary retention and irregular per vaginal bleeding. Ultrasound and Doppler imaging revealed a heterogeneous mass in the endometrial cavity with internal vascularity. Magnetic resonance imaging (MRI) revealed a large lobulated mass in the endometrial cavity extending into the vagina, causing local mass effect. Multiple linear hypointense bands on magnetic resonance T2 weighted (T2wt) images were characteristic of ESS. MRI is a very useful imaging modality in characterizing the lesion and also for the staging. It is necessary to distinguish these tumors from benign as well as other uterine malignancies for better management. We also review relevant literature discussing imaging findings of ESS.Downloads Published Issue Section License Copyright (c) 2024 Journal of Radiology Case Reports This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. The publisher holds the copyright to the published articles and contents. However, the articles in this journal are open-access articles distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 License, which permits reproduction and distribution, provided the original work is properly cited. The publisher and author have the right to use the text, images and other multimedia contents from the submitted work for further usage in affiliated programs. Commercial use and derivative works are not permitted, unless explicitly allowed by the publisher.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-09-20T09:27:46.357103+00:00
unpaywall
last seen: 2026-09-20T06:29:17.529187+00:00